ARTICLE | Distillery Therapeutics
Musculoskeletal
November 30, 2016 2:08 PM UTC
Patient sample and rabbit studies suggest sclerostin or other inhibitors of canonical WNT signaling could help treat joint injury. In fibrocartilage samples from 12 patients undergoing temporomandibul...
BCIQ Company Profiles
BCIQ Target Profiles